ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,534Medicare Part D Prescriptions Filled, Including Refills

Rank: 341 out of 2888

$645K Total Retail Price of All Prescriptions

Rank: 557 out of 2888

602 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 602 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 7,303 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
AMLODIPINE BESYLATE 770 524 1 5
ENALAPRIL MALEATE 492 297 2 49
LOSARTAN POTASSIUM 486 311 3 18
METFORMIN HCL ER 479 277 4 53
LISINOPRIL 457 273 5 3
HYDROCHLOROTHIAZIDE 439 333 6 15
OMEPRAZOLE 436 270 7 7
METOPROLOL SUCCINATE 367 224 8 11
PRAVASTATIN SODIUM 358 205 9 12
ATORVASTATIN CALCIUM 323 213 10 9
LOVASTATIN 302 184 11 41
LEVOTHYROXINE SODIUM 289 181 12 1
CRESTOR 268 164 13 20
GLYBURIDE-METFORMIN HCL 240 136 R 14 64
METOPROLOL TARTRATE 213 118 15 10
TRAMADOL HCL 206 103 16 16
SERTRALINE HCL 186 96 17 27
FUROSEMIDE 178 86 18 6
NEXIUM 173 68 19 19
METFORMIN HCL 167 78 20 8
ALENDRONATE SODIUM 165 140 21 23
LANTUS 163 73 22 45
GABAPENTIN 156 73 23 13
JANUVIA 132 99 24 48
ATENOLOL 130 90 25 25
SIMVASTATIN 124 76 26 2
TAMSULOSIN HCL 124 89 26 29
KLOR-CON 10 115 96 28 195
GLIPIZIDE 112 84 29 50
HYDROCODONE-ACETAMINOPHEN 110 55 S3 30 4
NOVOLOG FLEXPEN 95 39 31 171
GLYBURIDE MICRONIZED 95 42 R 31 324
PEN NEEDLE 90 39 33 110
CLOPIDOGREL 89 46 34 30
DIOVAN 88 60 35 35
SURE COMFORT 87 42 36 276
DOXAZOSIN MESYLATE 86 43 37 94
LANTUS SOLOSTAR 84 32 38 92
LIPITOR 83 57 39 78
IBUPROFEN 82 33 40 87
ISOSORBIDE MONONITRATE ER 79 52 41 51
CARVEDILOL 77 24 42 21
WARFARIN SODIUM 72 33 43 22
RANITIDINE HCL 70 18 44 56
HYDRALAZINE HCL 70 52 44 59
PLAVIX 68 34 46 40
ACETAMINOPHEN-CODEINE 68 31 S3 46 147
INSULIN SYRINGE 65 24 48 86
FLUOXETINE HCL 65 18 48 83
NAPROXEN 64 37 50 80
POLYETHYLENE GLYCOL 3350 58 47 51 93
CILOSTAZOL 58 54 51 165
PANTOPRAZOLE SODIUM 53 18 53 33
NOVOLOG 50 23 54 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.